RACIAL AND GENDER DIFFERENCES IN N-ACETYLTRANSFERASE, XANTHINE-OXIDASE, AND CYP1A2 ACTIVITIES

被引:262
作者
RELLING, MV
LIN, JS
AYERS, GD
EVANS, WE
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT, MEMPHIS, TN 38105 USA
[2] UNIV TENNESSEE CTR HLTH SCI, DEPT CLIN PHARM, MEMPHIS, TN 38163 USA
[3] UNIV TENNESSEE CTR HLTH SCI, DEPT PEDIAT, MEMPHIS, TN 38163 USA
关键词
D O I
10.1038/clpt.1992.203
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. The urinary molar concentration ratios of several caffeine metabolites are indicators of specific drug metabolizing enzyme activities. The ratios of 5-acetyl-amino-6-formylamino-3-methyluracil (AFMU) to 1-methylxanthine (1X), AFMU to IX plus 1-methyluric acid (1U), and AFMU to 1X + 1U + AFMU are indicative of N-acetyltransferase (NAT) activity; the ratios of 1U to 1X and 1U to 1U + 1X indicate xanthine oxidase activity; and the ratio of the sum of 7-demethylated metabolites (AFMU + 1X + 1U) to the precursor for all three compounds, paraxanthine (PX), is a putative indicator of CYP1A2 oxidative activity. Our objective was to discern whether there are race-, gender-, and age-related differences in these indexes of drug-metabolizing activity. Methods: In 342 normal healthy unrelated subjects, metabolites were measured in urine collected after administration of low-dose caffeine. Results: By two-way analysis of variance, NAT activity was higher in black subjects than in white subjects when assessed as AFMU/(1U + 1X) or as AFMU/(AFMU + 1U + IX) (p = 0.001 and p = 0.002, respectively), but less so by use of AFMU/1X (p = 0.08). Xanthine oxidase activity, as assessed by IU/1X or as 1U/(1U + 1X), was lower in black subjects than in white subjects (p = 0.02 and p = 0.001, respectively) and was lower in males than in females (p = 0.001 for both ratios). Females had higher AFMU/IX ratios (p = 0.03) because of higher xanthine oxidase activity. In a model in which AFMU/IX was the dependent variable and race, sex, age, and an index of xanthine oxidase (1U/1X) were independent variables, only race and 1U/1X were significant determinants of this NAT index (p = 0.003 and p < 0.001, respectively). The CYP1A2 ratio was lower in black subjects (p = 0.036) and in females (p 0.015). Conclusion: Racial and gender differences in xanthine oxidase activity render the AFMU/IX ratio less reliable as an assessment of NAT activity in a heterogeneous population compared with the AFMU/(1U + 1X) or AFMU/(AFMU + 1U + 1X) ratios. The observed racial and gender differences in NAT, xanthine oxidase, and CYP1A2 activities may have implications for racial and gender differences in drug effects and carcinogen biotransformation.
引用
收藏
页码:643 / 658
页数:16
相关论文
共 50 条
  • [1] BERTHOU F, 1991, DRUG METAB DISPOS, V19, P561
  • [2] MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS
    BLUM, M
    DEMIERRE, A
    GRANT, DM
    HEIM, M
    MEYER, UA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) : 5237 - 5241
  • [3] CHANGES IN RATE AND PATTERN OF CAFFEINE METABOLISM AFTER CIGARETTE ABSTINENCE
    BROWN, CR
    JACOB, P
    WILSON, M
    BENOWITZ, NL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 488 - 491
  • [4] CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
  • [5] A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE
    CAMPBELL, ME
    SPIELBERG, SP
    KALOW, W
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) : 157 - 165
  • [6] MATURATION OF CAFFEINE METABOLIC PATHWAYS IN INFANCY
    CARRIER, O
    PONS, G
    REY, E
    RICHARD, MO
    MORAN, C
    BADOUAL, J
    OLIVE, G
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) : 145 - 151
  • [7] CARTWRIGHT RA, 1982, LANCET, V2, P842
  • [8] DEGUCHI T, 1990, J BIOL CHEM, V265, P1275
  • [9] DRAYER E, 1977, CLIN PHARMACOL THER, V3, P22
  • [10] GENETICS OF ISONIAZID METABOLISM IN CAUCASIAN NEGRO + JAPANESE POPULATIONS
    DUFOUR, AP
    KNIGHT, RA
    HARRIS, HW
    [J]. SCIENCE, 1964, 145 (363) : 391 - &